Advertisement
Advertisement
Trending on Dermatology Times
1
Icotrokinra Sustains Skin Clearance at High-Impact Psoriasis Sites Through 2 Years
2
Litifilimab Demonstrates Durable Skin Clearance Through 52 Weeks in Cutaneous Lupus
3
Q&A: Three-Year Nemolizumab Data Highlight Sustained Control of Atopic Dermatitis
4
Ritlecitinib Improves Repigmentation in Nonsegmental Vitiligo
5




